Personalweb Tech News Today

Antibody-drug conjugate (ADC) is a promising class of cancer treatments with accelerating U.S. Food and Drug Administration (FDA) approval and rapidly growing market size as discussed...

In a split decision, the US Court of Appeals for the Federal Circuit affirmed a district court’s award of more than $5 million in attorneys’ fees, finding that the district court did...

The U.S. Court of Appeals for the Federal Circuit expanded the century-old Kessler doctrine in the 2020 In re: PersonalWeb Technologies LLC decision to give preclusive effect to issues...